Integrated Investment Consultants »

United Therapeutics Corporation shares owned by Integrated Investment Consultants

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Integrated Investment Consultants from 13F filings

Historical chart of Integrated Investment Consultants investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Integrated Investment Consultants consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Integrated Investment Consultants

Quarter filed Position value Share count Share price at filing
2025-09-30 $480k 1.1k 419.21
2025-06-30 $248k 863 287.35
2025-03-31 $266k 863 308.27

More positions owned by Integrated Investment Consultants

Ishares Russell 1000 Growth Etf Etf (IWF)
Ishares Russell Mid-cap Growth Etf Etf (IWP)
Uwm Holdings Corporation Com Cl A Stock (UWMC)
Ishares Short Duration Bond Active Etf Etf (NEAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Ishares Core Msci Eafe Etf Etf (IEFA)
Schwab Us Dividend Equity Etf Etf (SCHD)
Vanguard Russell 1000 Growth Etf Etf (VONG)
Microsoft Corp Stock (MSFT)
Vanguard S&p Small-cap 600 Value Etf Etf (VIOV)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Morningstar Mid-cap Growth Etf Etf (IMCG)
State Street Spdr Portfolio Emerging Markets Etf Etf (SPEM)

View all positions for Integrated Investment Consultants

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation